The traditional view of Vitamin D is that it is essential for bone health. Vitamin D deficiency is linked to rickets in children; and osteomalacia in adults. These two conditions can lead to bone deformities with an increased risk of fractures.
Beyond the focus on bone health the evidence for other health effects of Vitamin D has been inconsistent and controversial. Claims have been made about the possible benefits of Vitamin D supplementation in reducing the risk of cancer, heart disease and strokes. Enhancements to the immune system have also been postulated with potential impacts on infections and conditions such as multiple sclerosis.
Research from the University of California published in the current edition of the American Journal of Public Health shows that individuals with lower levels of vitamin D in their blood are twice as likely to die prematurely compared with those with higher levels of Vitamin D. The research involved collecting and re-analysing the data from 32 separate studies involving 566,583 participants — quite a good size sample .
In a separate study published in the current edition of the British Medical Journal, not only was the risk from low blood levels of Vitamin D confirmed – for cancer as well as for heart disease – but supplementation with vitamin D was actually demonstrated to reduce such death rates.
A recent nationwide survey showed that more than 50 per cent of the UK adult population has insufficient levels of Vitamin D and that 16 per cent have severe deficiency during winter and spring. Most of vitamin D comes from sunlight with about a further 10 per cent being derived from diet – especially oily fish, eggs and cereals. There are also a variety of Vitamin D supplements available from pharmacists or on prescription.
Health screening including annual Vitamin D testing (25-OH Vitamin D) would now seem to be a very sensible choice for all adults.
Give something clever this Christmas – a year’s subscription to The Spectator for just £75. And we’ll give you a free bottle of champagne. Click here.